HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
NYSE:DOC - New York Stock Exchange, Inc. - US42250P1030 - REIT - Currency: USD
DOC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. While DOC is still in line with the averages on profitability rating, there are concerns on its financial health. DOC has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year DOC was profitable.
DOC had a positive operating cash flow in the past year.
Each year in the past 5 years DOC has been profitable.
In the past 5 years DOC always reported a positive cash flow from operatings.
1.2 Ratios
DOC has a Return On Assets of 1.22%. This is in the better half of the industry: DOC outperforms 60.77% of its industry peers.
DOC's Return On Equity of 2.89% is in line compared to the rest of the industry. DOC outperforms 57.69% of its industry peers.
With a Return On Invested Capital value of 2.63%, DOC perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
DOC had an Average Return On Invested Capital over the past 3 years of 2.39%. This is in line with the industry average of 3.19%.
The last Return On Invested Capital (2.63%) for DOC is above the 3 year average (2.39%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.22% | ||
| ROE | 2.89% | ||
| ROIC | 2.63% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.39%
ROIC(5y)2.05%
1.3 Margins
DOC has a Profit Margin of 8.98%. This is comparable to the rest of the industry: DOC outperforms 60.00% of its industry peers.
In the last couple of years the Profit Margin of DOC has grown nicely.
DOC has a Operating Margin (21.71%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DOC has declined.
Looking at the Gross Margin, with a value of 64.46%, DOC is doing worse than 61.54% of the companies in the same industry.
DOC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.71% | ||
| PM (TTM) | 8.98% | ||
| GM | 64.46% |
OM growth 3Y5.47%
OM growth 5Y-2.9%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y2.83%
GM growth 5Y-0.77%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOC is destroying value.
DOC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DOC has been increased compared to 5 years ago.
The debt/assets ratio for DOC has remained at the same level compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.42, we must say that DOC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DOC (0.42) is comparable to the rest of the industry.
The Debt to FCF ratio of DOC is 18.70, which is on the high side as it means it would take DOC, 18.70 years of fcf income to pay off all of its debts.
DOC's Debt to FCF ratio of 18.70 is fine compared to the rest of the industry. DOC outperforms 75.38% of its industry peers.
DOC has a Debt/Equity ratio of 0.94. This is a neutral value indicating DOC is somewhat dependend on debt financing.
DOC has a Debt to Equity ratio of 0.94. This is in the better half of the industry: DOC outperforms 60.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 18.7 | ||
| Altman-Z | 0.42 |
ROIC/WACC0.39
WACC6.66%
2.3 Liquidity
DOC has a Current Ratio of 0.08. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
DOC has a worse Current ratio (0.08) than 95.38% of its industry peers.
A Quick Ratio of 0.08 indicates that DOC may have some problems paying its short term obligations.
DOC has a Quick ratio of 0.08. This is amonst the worse of the industry: DOC underperforms 95.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.08 | ||
| Quick Ratio | 0.08 |
3. Growth
3.1 Past
The earnings per share for DOC have decreased strongly by -37.50% in the last year.
DOC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.64% yearly.
Looking at the last year, DOC shows a very strong growth in Revenue. The Revenue has grown by 23.82%.
DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.84% yearly.
EPS 1Y (TTM)-37.5%
EPS 3Y-2.7%
EPS 5Y-2.64%
EPS Q2Q%-92.31%
Revenue 1Y (TTM)23.82%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%26.07%
3.2 Future
The Earnings Per Share is expected to decrease by -4.17% on average over the next years.
DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.12% yearly.
EPS Next Y-36.19%
EPS Next 2Y-10.11%
EPS Next 3Y-5.76%
EPS Next 5Y-4.17%
Revenue Next Year4.15%
Revenue Next 2Y4.12%
Revenue Next 3Y4.04%
Revenue Next 5Y4.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DOC is valuated quite expensively with a Price/Earnings ratio of 54.50.
The rest of the industry has a similar Price/Earnings ratio as DOC.
Compared to an average S&P500 Price/Earnings ratio of 28.33, DOC is valued quite expensively.
Based on the Price/Forward Earnings ratio of 85.42, the valuation of DOC can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.37, DOC is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.5 | ||
| Fwd PE | 85.42 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DOC is on the same level as its industry peers.
DOC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DOC is cheaper than 67.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.58 | ||
| EV/EBITDA | 13.23 |
4.3 Compensation for Growth
DOC's earnings are expected to decrease with -5.76% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.11%
EPS Next 3Y-5.76%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.51%, DOC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 16.87, DOC has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.51, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.51% |
5.2 History
The dividend of DOC decreases each year by -2.76%.
DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DOC pays out 327.90% of its income as dividend. This is not a sustainable payout ratio.
DOC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP327.9%
EPS Next 2Y-10.11%
EPS Next 3Y-5.76%
NYSE:DOC (4/23/2025, 10:46:56 AM)
19.0757
+0.27 (+1.41%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners94.75%
Inst Owner Change0%
Ins Owners0.28%
Ins Owner Change-1.87%
Market Cap13.33B
Analysts80.83
Price Target25.02 (31.16%)
Short Float %2.23%
Short Ratio3.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.51% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP327.9%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.57%
Min EPS beat(2)-79.16%
Max EPS beat(2)76.02%
EPS beat(4)2
Avg EPS beat(4)10.32%
Min EPS beat(4)-86.62%
Max EPS beat(4)131.02%
EPS beat(8)5
Avg EPS beat(8)31.06%
EPS beat(12)8
Avg EPS beat(12)58.38%
EPS beat(16)9
Avg EPS beat(16)40.26%
Revenue beat(2)2
Avg Revenue beat(2)1.14%
Min Revenue beat(2)0.34%
Max Revenue beat(2)1.94%
Revenue beat(4)4
Avg Revenue beat(4)3.28%
Min Revenue beat(4)0.34%
Max Revenue beat(4)7.87%
Revenue beat(8)6
Avg Revenue beat(8)-7.44%
Revenue beat(12)8
Avg Revenue beat(12)-4.82%
Revenue beat(16)12
Avg Revenue beat(16)35.62%
PT rev (1m)-0.54%
PT rev (3m)-2.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.85%
EPS NY rev (1m)1.01%
EPS NY rev (3m)1.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.27%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.5 | ||
| Fwd PE | 85.42 | ||
| P/S | 4.93 | ||
| P/FCF | 28.58 | ||
| P/OCF | 12.45 | ||
| P/B | 1.59 | ||
| P/tB | 1.76 | ||
| EV/EBITDA | 13.23 |
EPS(TTM)0.35
EY1.83%
EPS(NY)0.22
Fwd EY1.17%
FCF(TTM)0.67
FCFY3.5%
OCF(TTM)1.53
OCFY8.03%
SpS3.87
BVpS12.03
TBVpS10.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.22% | ||
| ROE | 2.89% | ||
| ROCE | 3.33% | ||
| ROIC | 2.63% | ||
| ROICexc | 2.65% | ||
| ROICexgc | 2.94% | ||
| OM | 21.71% | ||
| PM (TTM) | 8.98% | ||
| GM | 64.46% | ||
| FCFM | 17.26% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.39%
ROIC(5y)2.05%
ROICexc(3y)2.4%
ROICexc(5y)2.06%
ROICexgc(3y)2.61%
ROICexgc(5y)2.23%
ROCE(3y)3.02%
ROCE(5y)2.59%
ROICexcg growth 3Y12%
ROICexcg growth 5Y7.99%
ROICexc growth 3Y11.28%
ROICexc growth 5Y7.36%
OM growth 3Y5.47%
OM growth 5Y-2.9%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y2.83%
GM growth 5Y-0.77%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 18.7 | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 57.16% | ||
| Cap/Sales | 22.38% | ||
| Interest Coverage | 2.35 | ||
| Cash Conversion | 65.13% | ||
| Profit Quality | 192.35% | ||
| Current Ratio | 0.08 | ||
| Quick Ratio | 0.08 | ||
| Altman-Z | 0.42 |
F-Score6
WACC6.66%
ROIC/WACC0.39
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.5%
EPS 3Y-2.7%
EPS 5Y-2.64%
EPS Q2Q%-92.31%
EPS Next Y-36.19%
EPS Next 2Y-10.11%
EPS Next 3Y-5.76%
EPS Next 5Y-4.17%
Revenue 1Y (TTM)23.82%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%26.07%
Revenue Next Year4.15%
Revenue Next 2Y4.12%
Revenue Next 3Y4.04%
Revenue Next 5Y4.12%
EBIT growth 1Y30.97%
EBIT growth 3Y18.66%
EBIT growth 5Y13.45%
EBIT Next Year237.64%
EBIT Next 3Y54.8%
EBIT Next 5Y33.17%
FCF growth 1Y122.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.95%
OCF growth 3Y10.42%
OCF growth 5Y4.82%